Impact News +++ Core Scientific: Aktionäre lehnen Fusion mit CoreWeave ab – Aktie zeigt sich volatil (Investing.com DE) +++ COREWEAVE Aktie -3,40%

BAVARIAN NORDIC Aktie

>BAVARIAN NORDIC Aktienkurs

32.1 EUR +0.2% (Tradegate)

Ask: 32.13 EUR / 320 Stück

Bid: 32.07 EUR / 320 Stück

Tagesumsatz: 278 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

Aktie über LYNX handeln

Intraday

1 Jahr

>BAVARIAN NORDIC Performance

1 Woche: -0,7%

1 Monat: +5,0%

3 Monate: +2,1%

6 Monate: +53,2%

1 Jahr: +9,1%

laufendes Jahr: +25,6%

>BAVARIAN NORDIC Aktie

Name:

BAVARIAN NORDIC

Land:

Dänemark

Sektor:

Gesundheit

ISIN/ Wkn:

DK0015998017 / 917165

Symbol/ Ticker:

BV3 (Frankfurt)

Kürzel:

FRA:BV3, ETR:BV3, BV3:GR

Index:

Webseite:

https://www.bavarian-nord..

Profil:

Bavarian Nordic A/S is a biotechnology and pharmac..
>Volltext..

Marktkapitalisierung:

2535.84 Mio. EUR

Unternehmenswert:

2331.72 Mio. EUR

Umsatz:

875.02 Mio. EUR

EBITDA:

289.23 Mio. EUR

Nettogewinn:

192.36 Mio. EUR

Gewinn je Aktie:

2.46 EUR

Schulden:

18.4 Mio. EUR

Liquide Mittel:

165.05 Mio. EUR

Operativer Cashflow:

238.89 Mio. EUR

Bargeldquote:

1.01

Umsatzwachstum:

6.46%

Gewinnwachstum:

101.02%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

BAVARIAN NORDIC

Letzte Datenerhebung:

30.10.25

>Kennzahlen

Aktien/ Unternehmen:

Aktien: 78.24 Mio. St.

Frei handelbar: 98.63%

Leerverk. Aktien: -

Rückkaufquote: 0.14%

Mitarbeiter: 1611

Umsatz/Mitarb.: 0.42 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 12.26%

Bewertung:

KGV: 12.88

KGV lG: 10.38

KUV: 2.89

KBV: 1.51

PEG-Ratio: 0.14

EV/EBITDA: 8.06

Rentabilität:

Bruttomarge: 53.22%

Gewinnmarge: 21.98%

Operative Marge: 22.38%

Managementeffizenz:

Gesamtkaprendite: 10.1%

Eigenkaprendite: 12.65%

>Peer Group

Es sind 20 Aktien bekannt.

>BAVARIAN NORDIC Chart & Kurs - Tradegate

>BAVARIAN NORDIC News

29.10.25 - 13:33	Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley (GlobeNewswire EN)
	COPENHAGEN, Denmark, October 29, 2025 – Pursuant to section 30 of the Danish Capital Markets Act, Bavarian Nordic A/S hereby announces that the Company has received notification from Morgan Stanley that they hold 5.20% of the shares and voting rights in Bavarian Nordic A/S as of October 23, 2025....

28.10.25 - 08:33	Bavarian Nordic Provides Further Support to Mpox Outbreak in Africa through Additional Donation of Vaccines (GlobeNewswire EN)
	COPENHAGEN, Denmark, October 28, 2025 – Bavarian Nordic announced today a donation of mpox vaccines to Africa CDC to support the response to the ongoing mpox outbreak in Africa....

24.10.25 - 11:54	Bavarian Nordic Takeover Standoff Turns Into Struggle for Power (Bloomberg)
	On Danish investment forums, retail shareholders in Bavarian Nordic A/S have for weeks traded messages like battlefield dispatches....

22.10.25 - 14:27	Bavarian Nordic: Platzt die Übernahme? (Der Aktionaer)
	Das Investorenduo Nordic Capital und Permira hat sich den Übernahmeprozess des europäischen Impfstoffherstellers Bavarian Nordic sicherlich einfacher vorgestellt. Nachdem die Private-Equity-Gesellschaften bereits den Übernahmepreis je Aktie nach oben gesetzt haben, müssen die Investoren den bestehenden Aktionären einen weiteren Schritt entgegenkommen....

21.10.25 - 15:12	Bavarian Bidders Cut Bar for Takeover as Investor Clash Deepens (Bloomberg)
	Nordic Capital and Permira lowered the acceptance level of their Bavarian Nordic A/S takeover bid for the second time, stepping up efforts to bypass shareholder opposition and secure the deal....

21.10.25 - 14:48	Consortium consisting of Nordic Capital and Permira lowers the minimum acceptance condition to 66 2/3% in respect of the takeover offer to the shareholders of Bavarian Nordic (GlobeNewswire EN)
	NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION...

16.10.25 - 11:51	Bavarian Nordic shares rise 2% after board reaffirms takeover recommendation (Investing.com)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

16.10.25 - 10:01	Bavarian Nordic Deal in Doubt as Shareholder Rejects New Offer (Bloomberg)
	Bavarian Nordic A/S's largest shareholder refused to back a sweetened takeover offer for the Danish vaccine maker, casting fresh uncertainty over the deal....

16.10.25 - 07:30	The Board of Directors maintains its recommendation in supplementary statement in respect of the improved takeover offer to the shareholders of Bavarian Nordic from the consortium led by Nordic Capital and Permira (GlobeNewswire EN)
	NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION...

15.10.25 - 20:39	Bavarian Nordic draws higher bid for take-private deal (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

15.10.25 - 18:36	Bavarian Nordic: Höheres Übernahme-Angebot mit Ansage! (Der Aktionaer)
	Der Übernahmeprozess um den europäischen Impfstoff-Entwickler Bavarian Nordic geht in die nächste Runde. Wie vom AKTIONÄR antizipiert, muss das bietende Investorenduo bestehend aus Permira und Nordic Capital beim Angebot nachbessern....

15.10.25 - 18:36	Nordic Capital, Permira Raise Bavarian Bid to Win Over Holdouts (Bloomberg)
	Nordic Capital and Permira raised their takeover bid for Bavarian Nordic A/S, seeking to win over shareholders after an earlier offer met resistance from key investors....

15.10.25 - 18:00	Consortium consisting of Nordic Capital and Permira increases offer price and extends offer period until 5 November 2025 in respect of the takeover offer to the shareholders of Bavarian Nordic (GlobeNewswire EN)
	NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION...

13.10.25 - 08:33	Bavarian Nordic shareholders are reminded of expiry of the offer period regarding the takeover offer from consortium consisting of Nordic Capital and Permira (GlobeNewswire EN)
	NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION...

09.10.25 - 14:24	Consortium consisting of Nordic Capital and Permira receives final regulatory approval in respect of its takeover offer to the shareholders of Bavarian Nordic (GlobeNewswire EN)
	NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION...

07.10.25 - 17:00	Bavarian Nordic Reports Positive Topline Data for Mpox/Smallpox Vaccine in Pediatric Population (GlobeNewswire EN)
	COPENHAGEN, Denmark, October 7, 2025 – Bavarian Nordic A/S (OMX: BAVA) today reported topline results from a clinical study of its MVA-BN® mpox/smallpox vaccine in children 2 to 11 years of age....

29.09.25 - 17:42	Bavarian Nordic Bidders Extend Offer Deadline, Maintain Price (Bloomberg)
	Nordic Capital and Permira extended the offer period for their Bavarian Nordic A/S takeover bid while sticking with their original price tag, holding firm despite pushback from key investors opposed to the valuation of the Danish vaccine maker....

29.09.25 - 16:39	Consortium consisting of Nordic Capital and Permira extends offer period until 14 October 2025 and provides update on regulatory approvals in respect of the takeover offer to the shareholders of Bavarian Nordic (GlobeNewswire EN)
	NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION...

12.09.25 - 14:12	More Bavarian Nordic Shareholders Unite Against PE Takeover (Bloomberg)
	A growing list of Bavarian Nordic A/S shareholders is pushing back against a private equity bid for the Danish vaccine maker by Nordic Capital and Permira....

05.09.25 - 10:06	Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise (GlobeNewswire EN)
	COPENHAGEN, Denmark, September 5, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Company's share capital has been increased by nominally DKK 3,818,710 as a consequence of employees' exercise of warrants....

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Der Gelobte glaubt an die Kompetenz der Jury. - Dr. Fritz P. Rinnhofer

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram